A. Geisler

发表

Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H

K. Klingel, H. Fechner, J. Kurreck, 2021, Viruses.

Pharmacological and Biological Antiviral Therapeutics for Cardiac Coxsackievirus Infections

S. Pinkert, H. Fechner, J. Kurreck, 2011, Molecules.

Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian Hamsters

R. Klopfleisch, S. Pinkert, H. Fechner, 2017, Molecular therapy. Nucleic acids.

Application of mutated miR-206 target sites enables skeletal muscle-specific silencing of transgene expression of cardiotropic AAV9 vectors.

S. Pinkert, H. Fechner, Tobias Grössl, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors

H. Fechner, H. Katus, O. Müller, 2011, Gene Therapy.

MicroRNA-regulated viral vectors for gene therapy.

H. Fechner, Henry Fechner, Anja Geisler, 2016, World journal of experimental medicine.

Coxsackievirus B3—Its Potential as an Oncolytic Virus

H. Fechner, J. Kurreck, A. Hazini, 2021, Viruses.

Variability in Cardiac miRNA-122 Level Determines Therapeutic Potential of miRNA-Regulated AAV Vectors

H. Fechner, J. Dulak, M. Zembala, 2020, Molecular therapy. Methods & clinical development.

Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.

R. Klopfleisch, H. Zeichhardt, S. Pinkert, 2015, The Journal of infectious diseases.

Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions.

Xiaomin Wang, S. Pinkert, H. Fechner, 2010, Antiviral research.

Lipid nanoparticle-encapsulated, chemically modified anti-adenoviral siRNAs inhibit hepatic adenovirus infection in immunosuppressed Syrian hamsters

R. Klopfleisch, K. Klingel, H. Fechner, 2023, Molecular therapy. Nucleic acids.

A Novel Artificial MicroRNA Expressing AAV Vector for Phospholamban Silencing in Cardiomyocytes Improves Ca2+ Uptake into the Sarcoplasmic Reticulum

U. Völker, S. Pinkert, H. Fechner, 2014, PloS one.

Correction: A Novel Artificial MicroRNA Expressing AAV Vector for Phospholamban Silencing in Cardiomyocytes Improves Ca2+ Uptake into the Sarcoplasmic Reticulum

U. Völker, S. Pinkert, H. Fechner, 2014, PLoS ONE.